S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
SWOG Cancer Research Network
Shengjing Hospital
Celgene
Celgene
University of Ulster
British Columbia Cancer Agency
Mundipharma Research GmbH & Co KG
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
Sheffield Children's NHS Foundation Trust
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
H. Lee Moffitt Cancer Center and Research Institute
University of Vermont
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University Hospitals Cleveland Medical Center
S.L.A. Pharma AG
Northwestern University
Northwestern University
Northwestern University
Mayo Clinic
Yan Chai Hospital
Rigshospitalet, Denmark
National Institutes of Health Clinical Center (CC)